Hims & Hers Health (HIMS) | Stock Overview & Key Data
Hims & Hers Health Performance Comparison
Stock Range
Today's Range
Low: $50.42
High: $52.71
on August 8, 2025
52 Week Range
Low: $13.47
High: $72.98
on September 6, 2024
on February 19, 2025
All-Time High: $72.98 on February 17, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$11.7B
EPS
0.79
P/E Ratio (TTM)
65.75
Forward P/E
112.91
P/B Ratio
20.84
PEG Ratio
112.91
Div. Yield
N/A
ROE
41.88%
Beta
2.087
Debt to Equity
185.60
Financial Highlights
Profitability
Gross Margin
76.39%
Operating Margin
4.91%
Profit Margin
9.61%
Returns and Earnings
Return on Assets (TTM)
6.94%
Return on Equity (TTM)
41.88%
EBITDA
$154.8M
Net Income (TTM)
$193.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$9.12
Quarterly Revenue Growth (YoY)
72.60%
Quarterly Earnings Growth (YoY)
219.70%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Hims & Hers Health HIMS | 11.74B Large-cap | -16.96% | 6.09% | 1.05% | 16.02% | 106.11% | 225.44% | 626.43% | 383.16% |
| Procter & Gamble PG | 359.87B Mega-cap | 1.90% | -2.77% | -3.24% | -8.37% | -7.51% | -9.99% | 4.66% | 13.63% |
| Colgate-Palmolive CL | 68.45B Large-cap | 1.41% | -8.09% | -6.76% | -1.48% | -6.47% | -17.03% | 5.48% | 9.92% |
| Kimberly-Clark KMB | 47.73B Large-cap | 1.50% | 9.02% | 1.17% | 2.94% | 9.98% | 7.78% | 9.30% | 3.15% |
| Kenvue KVUE | 40.95B Large-cap | -1.16% | 3.09% | -11.31% | 3.69% | 0.28% | 1.52% | -19.47% | -19.47% |
| Estee Lauder EL | 31.56B Large-cap | -0.38% | 6.00% | 48.09% | 31.99% | 22.59% | 1.73% | -67.07% | -57.24% |
Ownership & Short Interest
Insider Ownership
11.02%
Institutional Ownership
81.32%
Shares Short
65M
Short Ratio
1.42
Short % of Shares Outstanding
36.23%
Average 10-Day Volume
40M
Average 90-Day Volume
35M
Hims & Hers Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Hims & Hers Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HIMS's 52-week high and low?
- In the last 52 weeks, Hims & Hers Health reached a high of $72.98 (on February 19, 2025) and a low of $13.47 (on September 6, 2024).
- What is the market cap and P/E ratio for HIMS?
- Curious about Hims & Hers Health's size and valuation? Its market capitalization stands at 11.74B. When it comes to valuation, the P/E ratio (trailing twelve months) is 65.75, and the forward P/E (looking ahead) is 112.91.
- Does HIMS pay dividends? If so, what's the yield?
- As for dividends, Hims & Hers Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Hims & Hers Health's main competitors or similar companies to consider before investing?
When looking at Hims & Hers Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Procter & Gamble
PG359.87B Consumer Defensive Household & Personal Products -9.99% 4.66% Colgate-Palmolive
CL68.45B Consumer Defensive Household & Personal Products -17.03% 5.48% Kimberly-Clark
KMB47.73B Consumer Defensive Household & Personal Products 7.78% 9.30% Kenvue
KVUE40.95B Consumer Defensive Household & Personal Products 1.52% -19.47% Estee Lauder
EL31.56B Consumer Defensive Household & Personal Products 1.73% -67.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hims & Hers Health, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Hims & Hers Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 41.88%, the Debt to Equity ratio from the most recent quarter is 185.60, and its Gross Profit Margin stands at 76.39%.
- What is the recent revenue and earnings growth for HIMS?
- Looking at Hims & Hers Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 72.60%, and quarterly earnings saw a YoY growth of 219.70%.
- How much of HIMS stock is held by insiders and institutions?
- Wondering who owns Hims & Hers Health stock? Company insiders (like executives and directors) hold about 11.02% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 81.32%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.